Perry Stambolsky

1.3k total citations
14 papers, 1.0k citations indexed

About

Perry Stambolsky is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Perry Stambolsky has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Perry Stambolsky's work include Cancer-related Molecular Pathways (9 papers), Epigenetics and DNA Methylation (3 papers) and RNA Interference and Gene Delivery (3 papers). Perry Stambolsky is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Epigenetics and DNA Methylation (3 papers) and RNA Interference and Gene Delivery (3 papers). Perry Stambolsky collaborates with scholars based in Israel, France and Mali. Perry Stambolsky's co-authors include Varda Rotter, Lilach Weisz, Moshe Oren, Naomi Goldfinger, Igor Shats, Eyal Kalo, Ira Kogan, Yuval Tabach, Amir Zalcenstein and Giovanni Blandino and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cancer Cell.

In The Last Decade

Perry Stambolsky

14 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Perry Stambolsky Israel	11	700	588	272	134	108	14	1.0k
Irit Zurer Israel	10	590 0.8×	357 0.6×	228 0.8×	68 0.5×	102 0.9×	11	951
Kevin P. Rice United States	8	707 1.0×	605 1.0×	170 0.6×	149 1.1×	81 0.8×	10	1.1k
Ira Kogan-Sakin Israel	13	523 0.7×	447 0.8×	261 1.0×	74 0.6×	51 0.5×	13	869
Deug Y. Shin South Korea	16	949 1.4×	603 1.0×	206 0.8×	102 0.8×	47 0.4×	23	1.3k
L. Jayaraman United States	7	1.1k 1.6×	833 1.4×	184 0.7×	231 1.7×	48 0.4×	7	1.5k
H U Kontny United States	9	768 1.1×	429 0.7×	172 0.6×	71 0.5×	64 0.6×	10	1.1k
M. Gloria Luciani United Kingdom	15	812 1.2×	519 0.9×	163 0.6×	69 0.5×	63 0.6×	18	1.2k
Barbara Cecchinelli Italy	6	777 1.1×	560 1.0×	190 0.7×	83 0.6×	22 0.2×	6	991
Ashraful Islam United States	7	939 1.3×	316 0.5×	301 1.1×	37 0.3×	66 0.6×	12	1.2k
Russell Ericksen United States	14	523 0.7×	305 0.5×	271 1.0×	42 0.3×	49 0.5×	22	1.0k

Countries citing papers authored by Perry Stambolsky

Since Specialization

Citations

This map shows the geographic impact of Perry Stambolsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Stambolsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Stambolsky more than expected).

Fields of papers citing papers by Perry Stambolsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry Stambolsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Stambolsky. The network helps show where Perry Stambolsky may publish in the future.

Co-authorship network of co-authors of Perry Stambolsky

This figure shows the co-authorship network connecting the top 25 collaborators of Perry Stambolsky. A scholar is included among the top collaborators of Perry Stambolsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry Stambolsky. Perry Stambolsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kalo, Eyal, Ira Kogan-Sakin, Hilla Solomon, et al.. (2012). Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high ROS levels. Journal of Cell Science. 125(Pt 22). 5578–86. 93 indexed citations

Dell’Orso, Stefania, Giulia Fontemaggi, Perry Stambolsky, et al.. (2011). ChIP-on-Chip Analysis of In Vivo Mutant p53 Binding To Selected Gene Promoters. OMICS A Journal of Integrative Biology. 15(5). 305–312. 33 indexed citations

Madar, Shalom, Perry Stambolsky, & Varda Rotter. (2011). Unleash the wild type: Restoration of p53 suppressive activity in skin cancer. Cell Cycle. 10(5). 741–740. 3 indexed citations

Stambolsky, Perry, Yuval Tabach, Giulia Fontemaggi, et al.. (2010). Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53. Cancer Cell. 17(3). 273–285. 196 indexed citations

Kogan-Sakin, Ira, Yuval Tabach, Alina Molchadsky, et al.. (2010). Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells. Cell Death and Differentiation. 18(2). 271–281. 130 indexed citations

Stambolsky, Perry, Yuval Tabach, Giulia Fontemaggi, et al.. (2010). Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53. Cancer Cell. 17(5). 523–523. 7 indexed citations

Zemach, Assaf, Laju K. Paul, Perry Stambolsky, et al.. (2009). The C-terminal domain of the Arabidopsis AtMBD7 protein confers strong chromatin binding activity. Experimental Cell Research. 315(20). 3554–3562. 4 indexed citations

Kalo, Eyal, Yosef Buganim, Naomi Goldfinger, et al.. (2007). Mutant p53 Attenuates the SMAD-Dependent Transforming Growth Factor β1 (TGF-β1) Signaling Pathway by Repressing the Expression of TGF-β Receptor Type II. Molecular and Cellular Biology. 27(23). 8228–8242. 68 indexed citations

Buganim, Yosef, Eyal Kalo, Ran Brosh, et al.. (2006). Mutant p53 Protects Cells from 12- O -Tetradecanoylphorbol-13-Acetate–Induced Death by Attenuating Activating Transcription Factor 3 Induction. Cancer Research. 66(22). 10750–10759. 31 indexed citations

10.

Stambolsky, Perry, Lilach Weisz, Igor Shats, et al.. (2006). Regulation of AIF expression by p53. Cell Death and Differentiation. 13(12). 2140–2149. 169 indexed citations

11.

Zalcenstein, Amir, Lilach Weisz, Perry Stambolsky, et al.. (2005). Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53. Oncogene. 25(3). 359–369. 48 indexed citations

12.

Shats, Igor, Michael Milyavsky, Xiaohu Tang, et al.. (2004). p53-dependent Down-regulation of Telomerase Is Mediated by p21. Journal of Biological Chemistry. 279(49). 50976–50985. 119 indexed citations

13.

Erez, Neta, et al.. (2004). Hypoxia‐dependent regulation of PHD1: cloning and characterization of the human PHD1/EGLN2 gene promoter. FEBS Letters. 567(2-3). 311–315. 14 indexed citations

14.

Zalcenstein, Amir, Perry Stambolsky, Lilach Weisz, et al.. (2003). Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants. Oncogene. 22(36). 5667–5676. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact